Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 22 open reading frame 42 (C22orf42) is an uncharacterized human protein encoded by the C22orf42 gene located on chromosome 22. It is categorized as a protein-coding gene, with other known aliases including dJ90G24.6 and CB042_HUMAN. The function, molecular interactions, and clinical roles of C22orf42 remain largely unknown; as of current knowledge, there is no evidence to support its role as a therapeutic target such as a receptor, enzyme, transporter, or signaling protein. The protein has not been associated with any well-established biological pathways, specific diseases, known drug interactions, or use as a biomarker. Tissue-specific expression data and functional characterization are lacking, and there is no evidence in major protein databases or scientific literature to indicate that it is currently implicated in human disease or targeted by existing therapeutics. It is considered an uncharacterized or "dark" protein in human biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 22 open reading frame 42 (C22orf42).